Analysis · Litigation & decisions

Cold Calls Into Pain Cream Prescriptions: The Telemarketer at the Center of a Tennessee Telemedicine Fraud

Here's the thing about this case: according to federal prosecutors, the "telemedicine" service was a telemarketing operation that cold-called consumers, got their insurance information and sold the resulting prescriptions to pharmacies.

By Adam YoungPublished 2 min read
On this page

The telemarketer

Scott Roix was a Florida telemarketer who ran a business called HealthRight. According to court documents and trial evidence described by the Department of Justice (DOJ) on May 20, 2022:

  • Synergy Pharmacy in Palm Harbor, Florida, owned and run by Peter Bolos, Michael Palso and Andrew Assad, used Roix and HealthRight to generate prescriptions for Synergy and other pharmacies in the scheme.
  • The prescriptions were mostly for pain creams, scar creams and vitamins.
  • Roix used HealthRight's telemarketing platform as a "telemedicine" service, cold-calling consumers and deceiving them into accepting the drugs and handing over their insurance information.
  • HealthRight paid doctors to authorize the prescriptions, even though the doctors never talked to the patients and relied only on the telemarketers' screening.
  • That made the prescriptions invalid and the drugs misbranded under the Food, Drug, and Cosmetic Act.
  • From May 2015 through April 2018, Bolos, Palso and Assad paid Roix millions of dollars for at least 60,000 invalid prescriptions.

The sentences

Roix and HealthRight pleaded guilty in September 2018 in the Eastern District of Tennessee (case 2:18-cr-133). In May 2022, U.S. District Judge J. Ronnie Greer in Greeneville sentenced the other defendants. Bolos, convicted by a jury in December 2021, got 14 years. Palso got 33 months, Assad got 24 months and others got sentences ranging from probation to 42 months. HealthRight was ordered to pay $4.25 million in restitution. Roix's own sentencing was moved to June 15, 2022, and the DOJ releases cited here don't report its result.

The civil side

On August 2, 2019, DOJ also announced that Roix and his companies, HealthRight, Health Savings Solutions, Vici Marketing and Vici Marketing Group, agreed to pay $2.5 million to resolve False Claims Act allegations tied to kickbacks from pharmacies based on prescription volume and value. Part of it resolved a whistleblower suit, United States ex rel. Silva v. Vici Marketing (M.D. Fla.). The whistleblowers were to get $287,500. DOJ noted that the civil claims were allegations only, with no finding of liability.

The investigation involved the Department of Health and Human Services Office of Inspector General (HHS-OIG), the Food and Drug Administration Office of Criminal Investigations (FDA-OCI), the U.S. Postal Service Office of Inspector General (USPS-OIG), the Federal Bureau of Investigation (FBI), the Office of Personnel Management Office of Inspector General (OPM-OIG) and Homeland Security Investigations (HSI).

What to take from it

  1. Cold calls were the front end of a health care fraud scheme, according to DOJ.
  2. A telemarketing script took the place of a real doctor-patient relationship.
  3. Getting paid per prescription created criminal and civil exposure.
  4. The telemarketer faced both a guilty plea and a False Claims Act settlement.

That's it.

Not legal advice. TCPA.com provides general information, not legal advice, and is not a substitute for the advice of an attorney. Do not rely on it. Verify any action with your own licensed lawyer before you take it. See our Terms of Use.

Primary sources

  1. DOJ, Office of Public Affairs, "Defendants Sentenced in Tennessee for Multimillion-Dollar Nationwide Telemedicine Pharmacy Fraud Scheme" (May 20, 2022)
  2. DOJ, USAO Eastern District of Tennessee, "Telemarketer and His Companies Agree to Pay $2.5 Million to Settle Allegation That They Operated Telemedicine Schemes Involving Illegal Kickbacks and Unnecessary Prescription" (Aug. 2, 2019)
Adam Young, CEO of Ringba, Miami, Florida

About the Author: Adam Young

Adam Young is a 42-year-old entrepreneur from Miami, Florida. He is the CEO of Ringba, a call tracking and pay per call platform. Adam Young has been in telecom, call routing and performance marketing for over a decade, and is the author of The Pay Per Call Revolution. At TCPA.com, Adam Young writes about the Telephone Consumer Protection Act (TCPA), robocall enforcement, tech support fraud cases and what actions by the Department of Justice (DOJ), Federal Trade Commission (FTC) and Federal Communications Commission (FCC) mean for companies that make calls. His goal is to help companies stay compliant and keep scammers off the phone network.

More from Adam Young

Topics